Literature DB >> 2770307

MTT assay with reference to the clinical effect of chemotherapy.

A Suto1, T Kubota, Y Shimoyama, K Ishibiki, O Abe.   

Abstract

Tumor cells from 40 patients were tested by MTT assay. Five thousand to sixteen thousand tumor cells were plated into 96-well microplates with various concentrations of anticancer agents. After incubation for 48 h, the absorbance of each well was detected with an EIA reader and the effects of the agents were evaluated as positive when the inhibition rate was equal to or more than 50%. Normal cells were also processed under the same conditions, and the absorbance for normal cells was lower than that of tumor cells with statistical significance (P less than 0.05). The efficacy rates of MMC, 5-FU, ADM, and CDDP were 16.7, 8.3, 13.9, and 5.6%, respectively. The overall accuracy of this assay for clinical effects was 83.3%, with one false-positive and five true-negative cases. This MTT assay was also assumed to be useful for in vitro chemosensitivity testing of fresh surgical specimens.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2770307     DOI: 10.1002/jso.2930420108

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  14 in total

Review 1.  Chemotherapy sensitivity and resistance testing: to be "standard" or to be individualized, that is the question.

Authors:  Tetsuro Kubota; Larry Weisenthal
Journal:  Gastric Cancer       Date:  2006       Impact factor: 7.370

2.  The influence of stromal cells on the MTT assay (I)--In vitro chemosensitivity of the tumor and stromal cells to mitomycin C.

Authors:  A Suto
Journal:  Jpn J Surg       Date:  1991-05

3.  Regional chemotherapy for colorectal hepatic metastases: evidence for improved survival with new drug combinations.

Authors:  E Sutanto-Ward; Y Arisawa; S Tremiterra; E R Sigurdson
Journal:  Ann Surg Oncol       Date:  1996-01       Impact factor: 5.344

4.  Chemotherapy in experimental brain tumor, part 2: pretreatment with leukotriene C4 prolongs survival.

Authors:  P Black; C M Hand; J R Vender; S D Finkelstein
Journal:  J Neurooncol       Date:  1998-01       Impact factor: 4.130

5.  Test for chemotherapeutic sensitivity of cerebral gliomas: use of colorimetric MTT assay.

Authors:  J P Jordan; C M Hand; R S Markowitz; P Black
Journal:  J Neurooncol       Date:  1992-09       Impact factor: 4.130

6.  The predictability of clinical antitumor effects using two distinctive in vitro chemosensitivity tests: an analysis of true positive cases.

Authors:  Y Yamada; T Kubota; F Asanuma; T Yamada; T Suzuki; K Ishibiki; E Kawamura
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

7.  Selective toxicity of rose bengal to ovarian cancer cells in vitro.

Authors:  Steven B Koevary
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-06-25

8.  The influence of stromal cells on the MTT assay (II)--Study on the nude mouse system.

Authors:  A Suto
Journal:  Jpn J Surg       Date:  1991-05

9.  Long non-coding RNA NKILA regulates expression of HSP90α, NF-κB and β-catenin proteins in the MCF-7 breast cancer cell line.

Authors:  Mehmet Ali Tibatan; Evren Önay Uçar
Journal:  Mol Biol Rep       Date:  2021-06-14       Impact factor: 2.316

10.  Role of rat autologous skin fibroblasts and mechanism underlying the repair of depressed scars.

Authors:  Juan Zhao; Yan-Chun Liu; Yan-Hua Shi; Ya-Qin Xie; Hai-Peng Cui; Ying Li; Xiang-Jun Li; Li-Qun Ren
Journal:  Exp Ther Med       Date:  2016-06-08       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.